ZF Group has appointed Jake Morris as Site Leader of its UK Research and Development Hub in Solihull, effective January 1, 2026. With more than 25 years at ZF, Morris brings deep experience in ...
GSK has agreed to acquire RAPT Therapeutics in a transaction valued at approximately $2.2 billion, adding ozureprubart, a phase IIb long-acting anti-IgE antibody for food allergy prevention, to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback